— Know what they know.
Not Investment Advice

AARD Short Interest

Aardvark Therapeutics, Inc. Common Stock
1W: -66.7% 1M: -75.3% 3M: -75.6% YTD: -90.1% 1Y: -87.8%
$1.30
+0.22 (+20.37%)
 
Weekly Expected Move ±33.3%
$0 $1 $1 $2 $2
NASDAQ · Healthcare · Biotechnology · Tech Score Strong Sell · Power 25 · $28.5M mcap · 11M float · 3.72% daily turnover · Short 61% of daily vol
Credit Risk of going bust: higher than 91% of companies Debt: 2.3% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the riskiest tenth, about 1 in 20 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.02 (down 99%), Aardvark Therapeutics, Inc. Common Stock would be worth roughly what it owes.
Total debt $677K against a stock market value of $28.5M.
Distance to default 1.51 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $539K (short-term plus half of long-term), stock volatility 173.6%; Altman Z'' 5.92. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

Short Volume Summary

2026-10-26
52.3%
Short Ratio
of total volume
53.8%
20-Day Avg
46.7%
50-Day Avg
▲ Rising
5-Day Trend
1.5M
Short Volume
2.9M
Total Volume

Daily Short Volume Ratio

Short Volume vs Total Volume

Exchange Breakdown

2026-10-26
ExchangeShort VolumeTotal VolumeShort %
NASDAQ 1,456,042 2,797,961 52.0%
NYSE 74,205 132,514 56.0%
BATS 5,561 8,311 66.9%

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms